MINNEAPOLIS, Dec. 19, 2023 /PRNewswire/ — ShiraTronics, Inc., a trailblazing clinical-stage medical device company, today announced a landmark achievement with the successful implantation of its Chronic Migraine System in the world’s first six patients. This remarkable milestone represents a significant leap forward in neuromodulation, as the company unveils the first-ever fully implantable system for head location utilizing a minimally invasive approach.

Zoll Medical Corp. said a cyberattack may have exposed protected health information of current and former employees, dependants and beneficiaries.

Many ocular diseases involve changes in the structure and function of different regions of the back of the eye, also known as the “eye fundus.” For example, fluorescent pigments and tiny yellowish deposits called drusen accumulate under the retina in age-related macular degeneration, and the degeneration of neurons called ganglion cells is a defining characteristic of glaucoma.

The FDA today published a 510(k) premarket notification granting clearance to the Stork baby monitoring system from Masimo

Align Technology (Nasdaq:ALGN) announced today that the FDA granted 510(k) clearance for its Invisalign palatal expander system.

William Blair analysts said the product “should revolutionize how glaucoma is treated by addressing noncompliance with drops.”

B. Braun Medical announced that it launched its new CareSite Micro luer access device designed to make IV access safer.

JVC today announced the commercial availability of its FDA-cleared, self-fitting, over-the-counter (OTC) hearing aids.